MELISSA LAL: Open Payments
NPI 1164241824 · SACRAMENTO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$860 in 42 payments from 9 companies in 2025. Trend: 2023 $0 · 2024 $18 · 2025 $860
Food & beverage: $860
| Company | Payments | Amount |
|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 12 | $243 |
| Collegium Pharmaceutical, Inc. | 14 | $229 |
| Curonix LLC | 4 | $124 |
| Merz Pharmaceuticals, LLC | 3 | $85 |
| PFIZER INC. | 4 | $67 |
| ABBVIE INC. | 2 | $53 |
| Convatec Inc. | 1 | $27 |
| SCILEX PHARMACEUTICALS INC. | 1 | $16 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $15 |
Products named: RELISTOR, XTAMPZA, PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A, Xeomin, NURTEC ODT, UBRELVY, AQUACEL AG SURGICAL, QULIPTA.
Industry payments across CA — which companies pay providers there.
